Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alnylam Pharmaceuticals Inc. (ALNY)

65.86   -1.68 (-2.49%) 05-20 16:00
Open: 67.25 Pre. Close: 67.54
High: 67.71 Low: 65.81
Volume: 1,069,597 Market Cap: 7017M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 67.739 - 68.194 68.194 - 68.572
Low: 64.941 - 65.383 65.383 - 65.749
Close: 65.217 - 65.93 65.93 - 66.521

Technical analysis

as of: 2019-05-20 4:25:14 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 96.42     One year: 108.51
Support: Support1: 65.81    Support2: 54.75
Resistance: Resistance1: 82.55    Resistance2: 92.90
Pivot: 73.16
Moving Average: MA(5): 67.56     MA(20): 76.68
MA(100): 82.51     MA(250): 87.97
MACD: MACD(12,26): -5.30     Signal(9): -4.47
Stochastic oscillator: %K(14,3): 5.34     %D(3): 6.52
RSI: RSI(14): 27.43
52-week: High: 124.22  Low: 60.27  Change(%): -34.7
Average Vol(K): 3-Month: 97717  10-Days: 144772

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ALNY has closed above bottom band by 22.6%. Bollinger Bands are 72.8% wider than normal. The large width of the bands suggest high volatility as compared to ALNY's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Wed, 08 May 2019 02:13:59 Z
Can Pfizer Leap Over the Competition With This Potential Blockbuster?

Tue, 07 May 2019 20:10:28 Z
Regeneron (REGN) Stock Down on Earnings, Sales Miss in Q1

Tue, 07 May 2019 17:09:41 Z
Alnylam Pharmaceuticals is Now Oversold (ALNY)

Mon, 06 May 2019 16:13:17 Z
Alnylam Pharmaceuticals Continues Onpattro Launch With More to Come

Thu, 02 May 2019 23:11:11 Z
Regeneron (REGN) to Report Q1 Earnings: What's in Store?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 106.54
Shares Float (M) 106.00
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -7.760
EPS Est. Current Year -5.200
EPS Est. Next Year -5.330
EPS Est. Next Quarter -1.360
Forward EPS -5.580
Book Value (p.s.) 4.730
PEG Ratio -0.18
Profit Margin
Operating Margin -991.92
Return on Assets (ttm) -40.8
Return on Equity (ttm) -48.6
Qtrly Rev. Growth 52.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -595.46
Levered Free Cash Flow (M) -508.98

Stock Valuations

P/E -8.49
P/E Growth Ratio -0.02
P/BV 13.92
P/S 8254969856.00
P/CF -11.78

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.